Related Experiment Video
Updated: Jun 23, 2025
Receptor Autoradiography Protocol for the Localized Visualization of Angiotensin II Receptors
Published on: June 7, 2016
The Renin-Angiotensin System in Liver Disease
Mary S McGrath1, Brian J Wentworth2
1Department of Medicine, School of Medicine, University of Virginia, Charlottesville, VA 22903, USA.
Abstract:
The renin-angiotensin system (RAS) is a complex homeostatic entity with multiorgan systemic and local effects. Traditionally, RAS works in conjunction with the kidney to control effective arterial circulation, systemic vascular resistance, and electrolyte balance. However, chronic hepatic injury and resulting splanchnic dilation may disrupt this delicate balance. The role of RAS in liver disease, however, is even more extensive, modulating hepatic fibrosis and portal hypertension. Recognition of an alternative RAS pathway in the past few decades has changed our understanding of RAS in liver disease, and the concept of opposing vs. "rebalanced" forces is an ongoing focus of research. Whether RAS inhibition is beneficial in patients with chronic liver disease appears to be context-dependent, but further study is needed to optimize clinical management and reduce organ-specific morbidity and mortality. This review presents the current understanding of RAS in liver disease, acknowledges areas of uncertainty, and describes potential areas of future investigation.
Insights
The renin-angiotensin system (RAS) impacts liver disease by affecting fibrosis and portal hypertension. RAS inhibition
Area of Science:
- Cardiovascular Science
- Hepatology
- Renal Physiology
Background:
- The renin-angiotensin system (RAS) traditionally regulates circulation and electrolyte balance.
- Chronic liver injury disrupts RAS homeostasis, leading to splanchnic vasodilation.
- RAS significantly influences hepatic fibrosis and portal hypertension in liver disease.
Purpose of the Study:
- To review the current understanding of the renin-angiotensin system's role in liver disease.
- To highlight the complexities of RAS modulation in hepatic injury.
- To identify areas of uncertainty and future research directions for RAS in liver disease.
Main Methods:
- Literature review of studies on RAS and liver disease.
- Analysis of traditional and alternative RAS pathways.
- Synthesis of current research on RAS inhibition in chronic liver conditions.
Main Results:
- RAS plays a multifaceted role in liver disease beyond its renal functions.
- An alternative RAS pathway contributes to the complexity of its effects in the liver.
- The efficacy of RAS inhibition in liver disease is context-dependent.
Conclusions:
- RAS is a critical factor in liver disease progression, affecting fibrosis and portal hypertension.
- Further research is needed to clarify the role of RAS and optimize therapeutic strategies.
- Understanding RAS "rebalancing" is key to managing liver disease and reducing mortality.
Related Concept Videos
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
01:25Antihypertensive Drugs: Direct Renin Inhibitors
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:33Hormonal Regulation
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
01:13Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...